+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Influenza Vaccine Market Research Report by Vaccine Type, Age Group, Administration Route, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 234 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5012972
UP TO OFF until Dec 31st 2022
The Global Influenza Vaccine Market size was estimated at USD 6,705.34 million in 2021, USD 7,285.36 million in 2022, and is projected to grow at a CAGR of 8.83% to reach USD 11,141.69 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Influenza Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Vaccine Type, the market was studied across Inactivated, Live Attenuated, and Recombinant.
  • Based on Age Group, the market was studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.
  • Based on Administration Route, the market was studied across Intramuscular, Intranasal, and Oral.
  • Based on Distribution Channel, the market was studied across Government Medical Office, Hospital & Clinic, Retail Pharmacy, and Urgent Care Unit.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Influenza Vaccine market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Influenza Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Influenza Vaccine Market, including Abbott Laboratories, AstraZeneca PLC, Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol-Myers Squibb Company, CanSino Biologics Inc., Daiichi Sankyo Company, Limited, Emergent BioSolutions Inc., Eurocept Group, Fluart Innovative Vaccines Kft., Gamma Vaccines Pty Ltd, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Seqirus GmbH, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., and Swedish Orphan Biovitrum AB.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Influenza Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Influenza Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Influenza Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Influenza Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Influenza Vaccine Market?
6. What is the market share of the leading vendors in the Global Influenza Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the Global Influenza Vaccine Market?
Frequently Asked Questions about the Global Influenza Vaccine Market

What is the estimated value of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market was estimated to be valued at $6705.34 Million in 2021.

What is the growth rate of the Global Influenza Vaccine Market?

The growth rate of the Global Influenza Vaccine Market is 8.8%, with an estimated value of $11141.69 Million by 2027.

What is the forecasted size of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market is estimated to be worth $11141.69 Million by 2027.

Who are the key companies in the Global Influenza Vaccine Market?

Key companies in the Global Influenza Vaccine Market include Abbott Laboratories, AstraZeneca PLC, Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol, Myers Squibb Company, CanSino Biologics Inc. and Emergent BioSolutions Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Respiratory Disorders
5.1.1.2. Immunization as a Major Public Health Measures for the Prevention of Influenza Virus Infection
5.1.1.3. Clinical Trials and Vaccine Developments in Pipeline for Seasonal Influenzas
5.1.1.4. Government Initiatives Supporting Respiratory Health
5.1.2. Restraints
5.1.2.1. Lack of Inadequate Delivery Infrastructure & Limited Awareness
5.1.3. Opportunities
5.1.3.1. Increasing R&D Expenditure by Leading Market Players
5.1.3.2. Increasing Vaccine Availability through Distribution and Development Collaborations
5.1.3.3. Several Vaccine Candidates under Development against Animal Influenza A Virus
5.1.4. Challenges
5.1.4.1. Customers Trust and Confidence in Respiratory Disease Vaccination
5.1.4.2. Vaccine Research and Development are getting Challenged by the Constant Variations in Strains
5.2. Cumulative Impact of COVID-19
6. Influenza Vaccine Market, by Vaccine Type
6.1. Introduction
6.2. Inactivated
6.3. Live Attenuated
6.4. Recombinant
7. Influenza Vaccine Market, by Age Group
7.1. Introduction
7.2. Adolescent Vaccination
7.3. Adult Vaccination
7.4. Infant Vaccination
8. Influenza Vaccine Market, by Administration Route
8.1. Introduction
8.2. Intramuscular
8.3. Intranasal
8.4. Oral
9. Influenza Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Government Medical Office
9.3. Hospital & Clinic
9.4. Retail Pharmacy
9.5. Urgent Care Unit
10. Americas Influenza Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Influenza Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Influenza Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. AstraZeneca PLC
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bayer AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. BioDiem
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BiondVax Pharmaceuticals Ltd.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Bristol-Myers Squibb Company
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. CanSino Biologics Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Daiichi Sankyo Company, Limited
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Emergent BioSolutions Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Eurocept Group
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Fluart Innovative Vaccines Kft.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Gamma Vaccines Pty Ltd
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. GlaxoSmithKline PLC
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Johnson & Johnson
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Merck & Co., Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Pfizer Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Sanofi S.A.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Seqirus GmbH
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Serum Institute of India Pvt. Ltd.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Sinovac Biotech Ltd.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Swedish Orphan Biovitrum AB
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL INFLUENZA VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL INFLUENZA VACCINE MARKET DYNAMICS
FIGURE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY VACCINE TYPE, 2027
FIGURE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (%)
FIGURE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY AGE GROUP, 2027
FIGURE 20. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2021 VS 2027 (%)
FIGURE 24. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY ADMINISTRATION ROUTE, 2027
FIGURE 26. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 30. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 32. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, 2018-2027 (USD MILLION)
FIGURE 36. AMERICAS INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 40. ARGENTINA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. BRAZIL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. CANADA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. MEXICO INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 51. ASIA-PACIFIC INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. CHINA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. INDIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. INDONESIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. JAPAN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MALAYSIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SINGAPORE INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. TAIWAN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. THAILAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. VIETNAM INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 68. DENMARK INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EGYPT INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. FINLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. FRANCE INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. GERMANY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. ISRAEL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. ITALY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. NIGERIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. NORWAY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. POLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. QATAR INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. RUSSIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. SPAIN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. SWEDEN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. TURKEY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 90. GLOBAL INFLUENZA VACCINE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 91. GLOBAL INFLUENZA VACCINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL INFLUENZA VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. AMERICAS INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 51. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 52. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 53. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 54. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 55. ARGENTINA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 56. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 57. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 58. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 59. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 60. BRAZIL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 61. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 62. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 63. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 64. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 65. CANADA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 67. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 68. CANADA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 69. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 70. MEXICO INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 71. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 72. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 73. MEXICO INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 74. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 75. UNITED STATES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 77. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 78. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 79. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 80. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 87. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 88. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 89. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 90. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 91. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 92. CHINA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. CHINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 94. CHINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 95. CHINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 96. CHINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 97. INDIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 98. INDIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 99. INDIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 100. INDIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 101. INDIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 102. INDONESIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 104. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 105. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 106. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 107. JAPAN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. JAPAN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 109. JAPAN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 110. JAPAN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 111. JAPAN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 112. MALAYSIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 113. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 114. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 115. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 116. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 117. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 119. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 120. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 121. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 122. SINGAPORE INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 123. SINGAPORE INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 124. SINGAPORE INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 125. SINGAPORE INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 126. SINGAPORE INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 127. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 129. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 130. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 131. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 132. TAIWAN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. TAIWAN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 134. TAIWAN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 135. TAIWAN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 136. TAIWAN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 137. THAILAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 138. THAILAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 139. THAILAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 140. THAILAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 141. THAILAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 142. VIETNAM INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 143. VIETNAM INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 144. VIETNAM INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 145. VIETNAM INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 146. VIETNAM INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 153. DENMARK INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 154. DENMARK INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 155. DENMARK INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 156. DENMARK INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 157. DENMARK INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 158. EGYPT INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 159. EGYPT INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 160. EGYPT INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 161. EGYPT INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 162. EGYPT INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 163. FINLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 164. FINLAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 165. FINLAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 166. FINLAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 167. FINLAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 168. FRANCE INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. FRANCE INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 170. FRANCE INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 171. FRANCE INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 172. FRANCE INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 173. GERMANY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 174. GERMANY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 175. GERMANY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 176. GERMANY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 177. GERMANY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 178. ISRAEL INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 179. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 180. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 181. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 182. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 183. ITALY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 184. ITALY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 185. ITALY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 186. ITALY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 187. ITALY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 188. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 190. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 191. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 192. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 193. NIGERIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 194. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 195. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 196. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 197. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 198. NORWAY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 199. NORWAY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 200. NORWAY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 201. NORWAY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 202. NORWAY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 203. POLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 204. POLAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 205. POLAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 206. POLAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 207. POLAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 208. QATAR INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 209. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 210. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 211. QATAR INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 212. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 213. RUSSIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 214. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 215. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 216. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 217. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 218. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 219. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 220. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 221. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 222. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 223. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 224. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 225. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 226. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 227. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 228. SPAIN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 229. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 230. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 231. SPAIN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 232. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 233. SWEDEN INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 234. SWEDEN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 235. SWEDEN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 236. SWEDEN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 237. SWEDEN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 238. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 239. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 240. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 241. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 242. SWITZERLAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 243. TURKEY INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 244. TURKEY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 245. TURKEY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 246. TURKEY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 247. TURKEY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 253. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 254. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 255. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 256. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2027 (USD MILLION)
TABLE 257. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 258. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 259. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 260. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 261. GLOBAL INFLUENZA VACCINE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 262. GLOBAL INFLUENZA VACCINE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 263. GLOBAL INFLUENZA VACCINE MARKET MERGER & ACQUISITION
TABLE 264. GLOBAL INFLUENZA VACCINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 265. GLOBAL INFLUENZA VACCINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 266. GLOBAL INFLUENZA VACCINE MARKET INVESTMENT & FUNDING
TABLE 267. GLOBAL INFLUENZA VACCINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 268. GLOBAL INFLUENZA VACCINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Bristol-Myers Squibb Company
  • CanSino Biologics Inc.
  • Daiichi Sankyo Company, Limited
  • Emergent BioSolutions Inc.
  • Eurocept Group
  • Fluart Innovative Vaccines Kft.
  • Gamma Vaccines Pty Ltd
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Swedish Orphan Biovitrum AB

Methodology

Loading
LOADING...